Kings Global Biotech Limited, a active public limited company, was established on 09 June 2016 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33119PN2016PLC164905. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.81 Cr.
Formerly known as Kings Global Biotech Limited, Kingsglobal Biotech Limited. It upholds a compliant status. Its leadership includes Kartiki Ramesh Tupe (Additional Director), Manodnya Shashank Sapre (Whole-Time Director), Girish Bhimrao Jaiwal (Director). Past directors included Manodnya Shashank Sapre, Gangubai Bhimrao Jaiwal, Vaibhav Vilas Nagarkar. It holds ₹14.53 Cr open charges and ₹4.81 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mittal Chambers, J.M.Road, Shivajinagar, Pune, Maharashtra, 411030.
U33119PN2016PLC164905
164905
09 June 2016
₹2.00 Cr
₹1.81 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Kings Global Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kartiki Ramesh Tupe | Additional Director | 28 Sep 2022 | Current |
| Manodnya Shashank Sapre | Whole-Time Director | 14 Mar 2020 | Current |
| Girish Bhimrao Jaiwal | Director | 09 Jun 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2020 | Past |
| Pramod Abcsdd | Director | 18 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 14 Mar 2020 | Past |
| Pramod Abcsdd | Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kings Global Biotech Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.73% increase. The company also saw a substantial improvement in profitability, with a 10.09% increase in profit. The company's net worth Soared by an impressive increase of 15.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Kings Global Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹145,341,805.25
₹48,063,397.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Apr 2025 | The South Indian Bank Limited | ₹0.90 M | Open |
| 12 Dec 2024 | The South Indian Bank Limited | ₹1.20 M | Open |
| 25 Mar 2021 | Yes Bank Limited | ₹14.32 Cr | Open |
| 26 Mar 2019 | The South Indian Bank Limited | ₹4.81 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kings Global Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kings Global Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kings Global Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with The South Indian Bank Limited amounted to Rs. 0.09 Cr with Charge ID 101084677 was registered on 02 Apr 2025. was recorded as a recent event.
A charge with The South Indian Bank Limited amounted to Rs. 0.12 Cr with Charge ID 101022510 was registered on 12 Dec 2024. was recorded as a recent event.
The activity Kings Global Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Kings Global Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on Kartiki Ramesh Tupe was appointed as a Additional Director was appointed as a Additional Director on 28 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
Progress on A charge registered on 26 Mar 2019 via Charge ID 100254389 with The South Indian Bank Limited was fully satisfied on 04 Jan 2022. was documented.
The CIN of Kings Global Biotech Limited is U33119PN2016PLC164905.
Kings Global Biotech Limited is headquartered at Mittal Chambers, J.M.Road, Shivajinagar, Pune, Maharashtra, 411030.
Kings Global Biotech Limited was incorporated on 09 June 2016.
The current directors of Kings Global Biotech Limited are
The primary industry of Kings Global Biotech Limited is Trade.
Kings Global Biotech Limited is unlisted.
The authorized capital of Kings Global Biotech Limited is ₹2.00 Cr, and the paid-up capital is ₹1.81 Cr.
The compliance status of Kings Global Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX